References
- Moll AC, Kuik DJ, Bouter LM, Den Otter W, Bezemer PD, Koten JW, Imhof SM, Kuyt BP, Tan KEWP. Incidence and survival of retinoblastoma in the Netherlands: a register based study 1862-1995. Br J Ophthalmol. 1997;81:559–62. doi:https://doi.org/10.1136/bjo.81.7.559.
- Wongmas P, Jetsrisuparb A, Komvilaisak P, Suwanrungruang K, Choeyprasert W, Sriplung H, Wiangnon S. Incidences, trends and long term outcomes of retinoblastoma in three cancer registries, Thailand. Asian Pac J Cancer Prev. 2015;16:32–38. doi:https://doi.org/10.7314/APJCP.2015.16.16.6899.
- Doz F, Brisse HJ, Stoppa-Lyonnet D et al. Retinoblastoma. In: Pinkerton R, Plowman P, Pieters R, (Eds). Pediatric oncology. Arnold, London; 2004. p. 323–38.
- Fabian ID, Abdallah E, Abdullahi S, Abdulqader RA, Boubacar SA, Ademola-Popoola DS, Adio A, Afshar AR, Aggarwal P, Aghaji AE, et al.; on behalf of the Global Retinoblastoma Study Group. Global retinoblastoma presentation and analysis by national income level. JAMA Oncol. 2020;6(5):685–695. doi:https://doi.org/10.1001/jamaoncol.2019.6716
- Abramson DH. The diagnosis of retinoblastoma. Bull N Y Acad Med. 1988;64:283–317.
- Dimaras H, Corson TW. Retinoblastoma, the visible CNS tumor: a review: DIMARAS and CORSON. J Neurosci Res. 2019;97(1):29–44. doi:https://doi.org/10.1002/jnr.24213.
- Aerts I, Lumbroso-Le Rouic L, Gauthier-Villars M, Brisse H, Doz F, Desjardins L. Retinoblastoma. Orphanet J Rare Dis. 2006;25(1):31. doi:https://doi.org/10.1186/1750-1172-1-31.
- De Graaf P, Goricke S, Rodjan F, Galluzzi P, Maeder P, Castelijns J, Brisse HJ; on behalf of the European Retinoblastoma Imaging Collaboration. Guidelines for imaging retinoblastoma: imaging principles and MRI standardization. Pediatr Radiol. 2012;42:2–14. doi:https://doi.org/10.1007/s00247-011-2201-5.
- Lumbroso-Le Rouic L, Aerts I, Lévy-Gabriel C, Dendale R, Sastre X, Esteve M, Asselain B, Bours D, Doz F, Desjardins L. Conservative treatments of intraocular retinoblastoma. Ophthalmology. 2008;115(8):1405–10. doi:https://doi.org/10.1016/j.ophtha.2007.11.009.
- Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology. 2010;117:1623–29. doi:https://doi.org/10.1016/j.ophtha.2009.12.030.
- Ghassemi F, Khodabande A. Risk definition and management strategies in retinoblastoma: current perspectives. Clin Ophthalmol. 2015;9:985–94. doi:https://doi.org/10.2147/OPTH.S59828.
- Chawla B, Hasan F, Azad R, Seth R, Upadhyay AD, Pathy S, Pandey RM. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol. 2016;100(2):172–78. doi:https://doi.org/10.1136/bjophthalmol-2015-306672.
- Nyamori JM, Kimani K, Njuguna MW, Dimaras H. Retinoblastoma referral pattern in Kenya. Middle East Afr J Ophthalmol. 2014;21(4):321–27. doi:https://doi.org/10.4103/0974-9233.142270.
- Shields CL, Shields JA, Baez KA, Cater J, De Potter PV. Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol. 1993;77:544–48. doi:https://doi.org/10.1136/bjo.77.9.544.
- Shields CL, Shields JA, Baez KA, Cater JR, De Potter P. Optic nerve invasion of retinoblastoma: metastatic potential and clinical risk factors. Cancer. 1994;73:692–98. doi:https://doi.org/10.1002/1097-0142(19940201)73:3<692::AID-CNCR2820730331>3.0.CO;2-8.
- Brisse HJ, Guesmi M, Aerts I, Sastre-Garau X, Savignoni A, Lumbroso-Le Rouic L, Desjardins L, Doz F, Asselain B, Bours D, et al. Relevance of CT and MRI in retinoblastoma for the diagnosis of postlaminar invasion with normal-size optic nerve: a retrospective study of 150 patients with histological comparison. Pediatr Radiol. 2007;37:649–56. doi:https://doi.org/10.1007/s00247-007-0491-4.
- Schueler AO, Hosten N, Bechrakis NE, Lemke AJ, Foerster P, Felix R, Foerster MH, Bornfeld N. High resolution magnetic resonance imaging of retinoblastoma. Br J Ophthalmol. 2003;87:330–35. doi:https://doi.org/10.1136/bjo.87.3.330.
- Marees T, Van Leeuwen FE, Schaapveld M, Imhof SM, De Boer MR, Kors WA, Ringens PJ, Moll AC. Risk of third malignancies and death after a second malignancy in retinoblastoma surviviors. Eur J Cancer. 2010;46:2052–58. doi:https://doi.org/10.1016/j.ejca.2010.03.029.
- Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. Am J Roentgenol. 2001;176:289–96. doi:https://doi.org/10.2214/ajr.176.2.1760289.
- John-Mikolajewski V, Messmer E, Sauerwein W, Freundlieb O; Orbital computed tomography. Does it help in diagnosing the infiltration of choroid, sclera and/or optic nerve in retinoblastoma? Ophthalmic Pediatr Genet. 1987;8:101–04. doi:https://doi.org/10.3109/13816818709028525.
- Olivecrona H, Agerberg PA, Huaman A. European radiology head and neck CT diagnosis of retinoblastoma with histopathologic correlations. Eur Radiol. 1994;4:307–13. doi:https://doi.org/10.1007/BF00599062.
- De Jong MC, De Graaf P, Noij DP, Göricke S, Maeder P, Galluzzi P, Brisse HJ, Moll AC, Castelijns JA; European Retinoblastoma Imaging Collaboration (ERIC). Diagnostic performance of magnetic resonance imaging and computed tomography for advanced retinoblastoma. A review and systemic meta-analysis. Ophthalmology. 2014;121:1109–18. doi:https://doi.org/10.1016/j.ophtha.2013.11.021.
- Gupta R, Vemuganti GK, Reddy VA, Honavar SG. Histopathologic risk factors in retinoblastoma in India. Arch Pathol Lab Med. 2009;31:325–29.
- Eagle RC Jr. High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study. Arch Pathol Lab Med. 2009;133:1199–202. doi:https://doi.org/10.5858/133.8.1203.
- Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56:1129–35. doi:https://doi.org/10.1016/S0895-4356(03)00177-X.
- Deeks JJ. Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ. 2001;323:157–62. doi:https://doi.org/10.1136/bmj.323.7305.157.
- Chawla B, Sharma S, Sen S, Azad R, Bajaj MS, Kashyap S, Pushker N, Ghose S. Correlation between clinical features, magnetic resonance imaging and histopathologic findings in retinoblastoma: a prospective study. Ophthalmology. 2012;119:850–56. doi:https://doi.org/10.1016/j.ophtha.2011.09.037.
- De Graaf P, Barkhof F, Moll AC, Imhof SM, Knol DL, Van Der Valk P, Castelijns JA. Retinoblastoma: MR imaging parameters in detection of tumor extent. Radiology. 2005;235:197–207. doi:https://doi.org/10.1148/radiol.2351031301.
- Mallipatna AC, Gallie BL, Chévez-Barrios P, et al. In: Amin MB, Edge SB, Greene FL (Eds). AJCC cancer staging manual. 8th ed. New York (NY): Springer; 2017. p. 819–831.